查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405768

体外肺模型市场规模、份额和趋势分析报告：2024-2030 年按类型、应用、最终用途、地区和细分市场进行的预测

In Vitro Lung Model Market Size, Share & Trends Analysis Report By Type (2D Model, 3D Model), By Application (Physiological Research, 3D Model Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

体外肺模型市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球体外肺模型市场规模将达到9.481亿美元，2024年至2030年复合年增长率为17.4%。

推动市场成长的因素包括越来越注重创造动物实验模型的替代品以及近年来全球呼吸系统相关疾病的增加。试管内肺模型帮助研究人员重现特定的呼吸系统疾病，并密切模仿这些疾病的细胞和分子特征，以开发潜在的治疗方案。因此，疾病建模有助于试管内肺模型的整体发展。此外，美国道协会 (HSUS) 报告称，美国每年约有 5,000 万隻动物被用于实验。为了减少虐待动物，《动物福利法》(AWA) 制定了旨在减少对动物进行有害实验的法规。

因此，近年来，世界各地对动物伦理待遇研究领域的认识和兴趣已变得引人注目。这种重视促进了全球对试管内肺模型的需求增加。此外，虽然动物维护和测试费用昂贵，但体外模型具有成本效益，特别是对于化合物和化学品的高通量筛检。这种成本效益对预算有限的研究人员和组织很有吸引力，使体外模型成为动物实验的可靠替代方案。主要参与企业正在采取各种策略，包括合作伙伴关係、併购、协议和产品发布，以扩大其全球足迹和产品系列。例如，2023 年 6 月，AlveoliX 宣布了一种新的器官晶载系统，包含创新的 3D 结构特征，使模仿任何器官变得更加方便。

体外肺部模型市场报告亮点

  • 由于方便、高效和全面，2D 模型类型将在 2023 年占据市场主导地位。
  • 药物研发和毒理学研究应用在 2023 年占据市场主导地位，因为它们在药物研发的早期阶段发挥着至关重要的作用。
  • 从最终用途来看，製药和生物技术公司因其在药物开发和研究中的重要作用而在 2023 年占据市场主导地位。
  • 由于该地区有主要企业和学术研究机构，北美将在 2023 年占据该行业的主导地位。
  • 在这个市场上运营的主要企业不断关注产品发布、合作伙伴关係和地理扩张，以维持其市场地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第 4 章 类型业务分析

  • 体外肺模型市场：产品变异分析
  • 2D模型
    • 2D 模型市场，2018-2030
  • 3D模型
    • 3D模型市场，2018-2030

第五章 应用业务分析

  • 体外肺部模型市场：应用变化分析
  • 药物研发/毒理学研究
    • 药物研发与毒性研究市场，2018-2030
  • 生理学调查
    • 生理研究市场，2018-2030
  • 3D模型开发
    • 3D模型开发市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第六章 最终用途业务分析

  • 体外肺部模型市场：最终用途变异分析
  • 学术研究所
    • 学术研究机构市场，2018-2030
  • 製药和生物技术公司
    • 製药和生物技术市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章 区域业务分析

  • 2023 年和 2030 年按地区分類的体外肺模型市场占有率
  • 北美洲
    • 2018-2030年北美体外肺模型市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲体外肺模型市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太体外肺模型市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年拉丁美洲体外肺模型市场
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东及非洲体外肺模型市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介
    • Epithelix
    • MATTEK
    • MIMETAS
    • Lonza
    • Emulate
    • AlveoliX AG
    • InSphero
    • CN Bio Innovations Ltd
    • ATTC Global
    • TissUse GmbH
Product Code: GVR-4-68040-159-8

In Vitro Lung Model Market Growth & Trends:

The global in vitro lung model market size is expected to reach USD 948.1 million by 2030, growing at a CAGR of 17.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth include increasing emphasis on creating substitutes for animal testing models, and recent global rise in respiratory-related disorders over the past few years. In vitro lung models help researchers replicate specific respiratory diseases, closely mimicking the cellular and molecular characteristics of these disorders for the development of potential treatment options. Thus, disease modeling contributes to the overall growth of in vitro lung models. Furthermore, as per The Humane Society of the United States (HSUS) report, about 50 million animals are used in experiments each year in the U.S. To mitigate cruelty to animals, the Animal Welfare Act (AWA) has established regulations aimed at reducing harmful experiments on animals.

Thus, over the past few years, there has been a notable global awareness and concern regarding the ethical treatment of animals in the research field. This emphasis has contributed to the increased demand for in vitro lung models worldwide. Furthermore, maintaining and testing on animals is expensive, whereas the use of in vitro models can be more cost-effective, especially for high-throughput screening of compounds and chemicals. This cost-effectiveness is appealing to researchers and organizations with limited budgets, making in vitro models a dependable alternative to animal testing. Key participants are adopting various strategies including partnerships, mergers & acquisitions, agreements, and product launches, to expand their global footprints and product portfolio. For instance, in June 2023, AlveoliX introduced a new organ-on-chip system that includes innovative 3D structure features, making mimicking any organ more convenient.

In Vitro Lung Model Market Report Highlights:

  • 2D model type dominated the market in 2023 due to their convenience, efficiency, and comprehensive nature
  • The drug discovery & toxicology studies application segment dominated the market in 2023 as these models play a pivotal role in the early stages of pharmaceutical research & development
  • Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 due to their critical role in drug development & research
  • North America dominated the industry in 2023 owing to the presence of key players as well as academic research institutions in the region
  • Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their market position

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory diseases
      • 3.2.1.2. Advancement in cell culture technology
      • 3.2.1.3. Increasing number of research activities being done towards pulmonary drug development
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professional
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. In Vitro Lung Model Market: Product Movement Analysis
  • 4.2. 2D Model
    • 4.2.1. 2D Model Market, 2018 - 2030 (USD Million)
  • 4.3. 3D Model
    • 4.3.1. 3D Model Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. In Vitro Lung Model Market: Application Movement Analysis
  • 5.2. Drug discovery and Toxicology Studies
    • 5.2.1. Drug discovery and toxicology studies Market, 2018 - 2030 (USD Million)
  • 5.3. Physiological Research
    • 5.3.1. Physiological Research Market, 2018 - 2030 (USD Million)
  • 5.4. 3D Model Development
    • 5.4.1. 3D Model Development Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. In Vitro Lung Model Market: End-use Movement Analysis
  • 6.2. Academic Research Institutes
    • 6.2.1. Academic Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical and Biotechnology Companies
    • 6.3.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. In Vitro Lung Model Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Epithelix
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. MATTEK
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. MIMETAS
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Emulate
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. AlveoliX AG
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. InSphero
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. CN Bio Innovations Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ATTC Global
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. TissUse GmbH
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 2 Global In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 3 Global In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 4 Global In Vitro Lung Model market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 North America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 6 North America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 7 North America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 8 North America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 14 Canada In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 15 Europe In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 16 Europe In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 17 Europe In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Europe In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 UK In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 20 UK In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 21 UK In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 Germany In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 Germany In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 24 Germany In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 France In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 26 France In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 27 France In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Italy In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Italy In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Italy In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 32 Spain In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 35 Sweden In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 38 Norway In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Denmark In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 41 Denmark In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Denmark In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 Japan In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 48 Japan In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 49 Japan In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 China In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 51 China In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 52 China In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 India In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 54 India In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 55 India In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Australia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 57 Australia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Australia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Thailand In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 63 Thailand In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Latin America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 66 Latin America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 69 Brazil In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 70 Brazil In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 72 Mexico In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 73 Mexico In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 75 Argentina In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 76 Argentina In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 78 MEA In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 79 MEA In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 80 MEA In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 81 MEA In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 82 South Africa In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 83 South Africa In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Saudi Arabia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 86 Saudi Arabia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 87 Saudi Arabia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 92 Kuwait In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 94 Key companies undertaking acquisitions
  • TABLE 95 Key companies launching new products/services
  • TABLE 96 Key companies undertaking collaborations and partnerships
  • TABLE 97 Key companies undertaking other initiatives

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 In Vitro Lung Model market segmentation
  • FIG. 8 Market snapshot, 2023
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global In Vitro Lung Model Market: Type movement analysis
  • FIG. 15 Global In Vitro Lung Model Market, for 2D Model, 2018 - 2030 (USD Million)
  • FIG. 16 Global In Vitro Lung Model Market, for 3D Model, 2018 - 2030 (USD Million)
  • FIG. 17 Global In Vitro Lung Model Market: application movement analysis
  • FIG. 18 Global In Vitro Lung Model Market, for drug discovery and toxicology studies, 2018 - 2030 (USD Million)
  • FIG. 19 Global In Vitro Lung Model Market, for 3D model development, 2018 - 2030 (USD Million)
  • FIG. 20 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global In Vitro Lung Model Market: end-use movement analysis
  • FIG. 22 Global In Vitro Lung Model Market, for academic research institutes, 2018 - 2030 (USD Million)
  • FIG. 23 Global In Vitro Lung Model Market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 24 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 25 Regional marketplace: Key takeaways
  • FIG. 26 Regional outlook, 2023 & 2030
  • FIG. 27 Global In Vitro Lung Model Market: Region movement analysis
  • FIG. 28 North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 29 U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 30 Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 31 Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 32 Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 33 UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 34 France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 35 Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 36 Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 37 Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 38 Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 39 Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 40 Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 41 Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 42 China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 43 India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 44 Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 45 South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 46 Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 47 Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 48 Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 49 Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 50 Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 51 Middle East and Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 52 South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 53 Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 54 UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 55 Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)